Bionik Laboratories (OTCMKTS:BNKL) Stock Crosses Above 50-Day Moving Average – Time to Sell?

Bionik Laboratories Corp. (OTCMKTS:BNKL)’s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0001. Bionik Laboratories shares last traded at $0.00, with a volume of 0 shares trading hands.

Bionik Laboratories Trading Down 100.0%

Bionik Laboratories Company Profile

Bionik Laboratories Corp., headquartered in Waltham, Massachusetts, designs, develops and markets robotics-based rehabilitation solutions and assistive devices for patients with neurological and mobility impairments. Its core product portfolio includes the ARKE lower limb exoskeleton for gait training and the InMotion series of upper extremity robotic therapy devices, such as InMotion ARM and InMotion WRIST. These systems leverage sensor-driven feedback and proprietary software to enable clinicians to deliver personalized motor rehabilitation programs.

Founded in 2008, Bionik established a foundation in exoskeleton and robotics technology before expanding its clinical product suite through strategic acquisitions and research collaborations.